COLL vs MTD: fair value comparison
Collegium Pharmaceutical, Inc. and Mettler-Toledo International Inc. · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, COLL currently sits closer to the top of our discount ranking. MTD carries the stronger quality grade.
| COLL | MTD | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $35.58 | $1,345.26 |
| 12-month range | $31.78–$47.11 | $1,183.57–$1,468.09 |
| Sector rank | #44 of 113 Healthcare | #47 of 113 Healthcare |
| Quality grade | C- | B |
| Leverage | High | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Declining |
| RSI zone | Oversold | Oversold |
| 50/200-day trend | Mixed | — |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: COLL fair value analysis · MTD fair value analysis